Arcutis Biotherapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Arcutis Biotherapeutics Inc.
Former names: Arcutis, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Westlake Village
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: ARQT
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001787306
EIN: 81-2974255

Board of directors

Follow this board

Amit Munshi · Director
Since 2025
Bhaskar Chaudhuri · Director
Since 2023
Christopher Peetz · Director
Since 2026
Halley E. Gilbert · Director
Since 2023
Howard G. Welgus · Director
Since 2023
Keith R. Leonard · Director
Since 2023
Neha Krishnamohan · Director
Since 2023
Patrick J. Heron · Director
Since 2023
Robert A. Scott · Director
Since 2026
Sue-Jean Lin · Director
Since 2023
Terrie Curran · Director
Since 2023
Todd Franklin Watanabe · Director · See Remarks
Since 2023

Director election results

Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 11 other boards. 11 are in the same sector.

Shared director Other board Same sector

Mirum Pharmaceuticals Inc. Same sector
via Christopher Peetz and Patrick J. Heron
CytomX Therapeutics Inc. Same sector
via Halley E. Gilbert
Damora Therapeutics Inc. Same sector
via Amit Munshi
Inhibikase Therapeutics Inc. Same sector
via Amit Munshi
Intuitive Surgical Inc. Same sector
via Keith R. Leonard
MBX Biosciences Inc. Same sector
via Patrick J. Heron
Phathom Pharmaceuticals Inc. Same sector
via Terrie Curran
Stevanato Group S.p.A. Same sector
via Sue-Jean Lin
Tarsus Pharmaceuticals Inc. Same sector
via Bhaskar Chaudhuri
Vaxcyte Inc. Same sector
via Halley E. Gilbert
Zura Bio Limited Same sector
via Amit Munshi

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $13,947,073; 68 sales by 10 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 4, 2026	Matsuda Masaru Officer (EVP, Chief Legal Officer)	Option exercise	+40,000	$3.64	$145,600
Nov 4, 2026	Matsuda Masaru Officer (EVP, Chief Legal Officer)	Open-market sale	−40,000	$34.32	$1,372,672
Nov 2, 2026	Todd Franklin Watanabe Director, Officer (See Remarks)	Open-market sale	−4,377	$31.86	$139,466
Nov 2, 2026	Burnett Patrick Officer (EVP, Chief Medical Officer)	Open-market sale	−943	$31.86	$30,047
Nov 2, 2026	Matsuda Masaru Officer (EVP, Chief Legal Officer)	Open-market sale	−1,219	$31.86	$38,841
Oct 23, 2026	Robert A. Scott Director	Grant or award	+2,819	—	—
Oct 15, 2026	Howard G. Welgus Director	Option exercise	+822	$6.52	$5,361
Oct 15, 2026	Howard G. Welgus Director	Option exercise	+1,018	$7.51	$7,645
Oct 15, 2026	Howard G. Welgus Director	Option exercise	+2,254	$8.63	$19,452
Oct 15, 2026	Howard G. Welgus Director	Open-market sale	−4,728	$26.93	$127,325
Sep 16, 2026	Matsuda Masaru Officer (See Remarks)	Open-market sale	−3,674	$25.00	$91,850
Sep 15, 2026	Howard G. Welgus Director	Option exercise	+822	$6.52	$5,359
Sep 15, 2026	Howard G. Welgus Director	Option exercise	+1,019	$7.51	$7,653
Sep 15, 2026	Howard G. Welgus Director	Option exercise	+2,255	$8.63	$19,461
Sep 15, 2026	Howard G. Welgus Director	Open-market sale	−4,730	$24.18	$114,371

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Arcutis Biotherapeutics Inc.

How many directors are on Arcutis Biotherapeutics Inc.'s board?

Arcutis Biotherapeutics Inc.'s board has 12 directors: Amit Munshi, Bhaskar Chaudhuri, Christopher Peetz, Halley E. Gilbert, Howard G. Welgus, Keith R. Leonard, Neha Krishnamohan, Patrick J. Heron, Robert A. Scott, Sue-Jean Lin and 2 others.

Are Arcutis Biotherapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Arcutis Biotherapeutics Inc. insiders made no open-market purchases and sold $13.9 million of shares in 68 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Arcutis Biotherapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="arcutis-biotherapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.